Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA grants fast track designation for recAP in acute kidney injury

April 27, 2016

Boehringer Ingelheim initiates phase I study of anti-CX3CR1 Nanobody from Ablynx alliance

April 21, 2016

TGI and Quark enter discovery and development collaboration

April 15, 2016

Eli Lilly develops PDE4B inhibitors

April 4, 2016

Kyorin and Kissei sign codevelopment and co-marketing agreement for KRP-114V in Japan

March 31, 2016

Positive topline results from pivotal phase III study of ferric citrate

March 30, 2016

First patients dosed in Quark Pharmaceuticals' pivotal studies

March 15, 2016

Astellas Pharma discloses muscarinic M3 receptor PAMs

March 14, 2016

Tesevatinib receives FDA orphan drug designation for the treatment of ARKPD

March 4, 2016

Oxalate descarboxylase receives FDA orphan drug designation for pediatric hyperoxaluria

March 3, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...